LNP Starter kits
Ready-to-use lipid nanoparticle kits, mirorring clinically validated Covid19 vaccine mRNA-LNP formulations, fully compatible with our TAMARA® microfluidic system.
In Partnership with Corden Pharma
Effortless start to LNP formulation
Simply resuspend, mix and use
Start from a trusted benchmark
Based on LNP formulation used in Covid19 mRNA vaccine
Efficient & Affordable (€750)
100 mg of lipids per kit (~50 mL RNA-LNP/up to 20 mg of RNA) for multiple runs
GMP quality LNP
GMP-like quality lipids for superior delivery performances
Features
High Quality RNA-LNP
High purity lipids
Clinically validated formulations
Ready to use LNP mix
LNP kits composition
| Kit name | ALC-0315 (Acuitas – BioNTech/Pfizer) | SM-102 (Moderna – Moderna) | LP-01 (Novartis – Intellia) |
|---|---|---|---|
| Ionizable lipid | ALC-0315 (46.3%) | SM-102 (50%) | LP-01 (45%) |
| Phospholipid | DSPC (9.4%) | DSPC (10%) | DSPC (9%) |
| Sterol lipid | Cholesterol (42.7%) | Cholesterol (38.5%) | Cholesterol (44%) |
| PEG-lipid | ALC-0159 (1.6%) | MPEG-2000-DMG (1.5%) | MPEG-2000-DMG (2%) |
| Typical applications | mRNA-LNP | mRNA-LNP | Gene editing / CRISPR-Cas9 |
Resources
Looking to get a quotation for our LNP kits?
Reach out to us to learn how we can help!